RHÖN-KLINIKUM Aktiengesellschaft

XTRA:RHK Stock Report

Market Cap: €930.4m

RHÖN-KLINIKUM Past Earnings Performance

Past criteria checks 4/6

RHÖN-KLINIKUM has been growing earnings at an average annual rate of 13.9%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 4.2% per year. RHÖN-KLINIKUM's return on equity is 3.6%, and it has net margins of 2.4%.

Key information

13.9%

Earnings growth rate

13.9%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate4.2%
Return on equity3.6%
Net Margin2.4%
Next Earnings Update27 Mar 2025

Recent past performance updates

Recent updates

RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't

Jun 26
RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't

RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

Apr 25
RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Mar 02
RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Dec 19
Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

Jul 13
Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

Jun 15
There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Aug 11
Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Apr 01
Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

May 14
Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

Revenue & Expenses Breakdown

How RHÖN-KLINIKUM makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XTRA:RHK Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,8354550
30 Jun 241,8024750
31 Mar 241,7674350
31 Dec 231,7353950
30 Sep 231,7143240
30 Jun 231,6942650
31 Mar 231,6903020
31 Dec 221,6612540
30 Sep 221,6403040
30 Jun 221,6283240
31 Mar 221,6022860
31 Dec 211,5912840
30 Sep 211,5571540
30 Jun 211,5541440
31 Mar 211,549720
31 Dec 201,546140
30 Sep 201,537810
30 Jun 201,5321930
31 Mar 201,5133140
31 Dec 191,4814340
30 Sep 191,4364050
30 Jun 191,4135260
31 Mar 191,3944760
31 Dec 181,3904950
30 Sep 181,4115550
30 Jun 181,3853650
31 Mar 181,3743760
31 Dec 171,3623560
30 Sep 171,340260
30 Jun 171,330450
31 Mar 171,3341450
31 Dec 161,3195660
30 Sep 161,29110160
30 Jun 161,27610560
31 Mar 161,25110370
31 Dec 151,2408550
30 Sep 151,2506650
30 Jun 151,2486260
31 Mar 151,300-13870
31 Dec 141,6661,226100
30 Sep 142,1711,245150
30 Jun 142,6611,250130
31 Mar 143,0981,459170
31 Dec 133,22387230

Quality Earnings: RHK has high quality earnings.

Growing Profit Margin: RHK's current net profit margins (2.4%) are higher than last year (1.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: RHK's earnings have grown by 13.9% per year over the past 5 years.

Accelerating Growth: RHK's earnings growth over the past year (40.5%) exceeds its 5-year average (13.9% per year).

Earnings vs Industry: RHK earnings growth over the past year (40.5%) did not outperform the Healthcare industry 40.5%.

Return on Equity

High ROE: RHK's Return on Equity (3.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 21:21
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RHÖN-KLINIKUM Aktiengesellschaft is covered by 36 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eileen RyanAlphaValue
Gerhard SchwarzBaader Helvea Equity Research
Thomas JonesBerenberg